Association of Serum Interlukin-6 and Transforming Growth Factor Beta with Response to Antiviral Therapy for Chronic Hepatitis C Patients - Egyptian Knowledge Bank - troweb

320067

Association of Serum Interlukin-6 and Transforming Growth Factor Beta with Response to Antiviral Therapy for Chronic Hepatitis C Patients

Article

Last updated: 05 Jan 2025

Overview Similar Items

Article

The association between Interleukins 6, 8, and 10 levels and response to treatment of the hepatitis C virus with direct-acting antiviral.

Article

Study of Interleukin-18 in Chronic hepatitis C virus related liver diseases

Article

Serum levels of interleukin-10 in both responders and non-responders to Direct-acting antivirals therapy for the hepatitis C virus

Article

Association Between Gut Flora and Response to Antiviral Therapy in Chronic Hepatitis C Patients

Article

Interleukin 17 levels used as diagnostic marker for following up hepatitis C virus treatment

Article

Correlation of Serum Hepatitis C Viral Load and Immunobiochemical biomarkers in Combined Therapy Treated Patients

Article

ROLE OF SERUM INTERLEUKIN – 10 AND INTERLEUKIN -28B GENE POLYMORPHISMS IN PREDICTING TREATMENT RESPONSE OF HEPATITIS C PATIENTS

Article

Immune profile of peripheral blood T-lymphocyte subpopulations in chronic hepatitis B

Article

Study of Serum Resistin Levels in Patients with Chronic Hepatitis C Viral Infection

Article

Serum Hepcidin In Patients With Chronic Hepatitis C And Its Relation To Treatment With Antiviral Drugs